Pharma groups: FDA should allow portals, emails for tracing products under DSCSA
Regulatory NewsJoanne S. Eglovitch
North AmericaPharmaceuticalsSupply Chain ManagementRegulatory NewsJoanne S. EglovitchNorth AmericaPharmaceuticalsSupply Chain Management